Masimo Proceeds With Danaher Merger Amid Shareholder Lawsuits
TipRanks (Thu, 23-Apr 6:18 PM ET)
Are MASI, CECO, MPX Obtaining Fair Deals for their Shareholders?
PRNewswire (Fri, 10-Apr 1:36 PM ET)
Telix Strengthens Board with Additional Director Appointments
Globe Newswire (Wed, 8-Apr 6:44 PM ET)
Business Wire (Tue, 7-Apr 10:14 PM ET)
Globe Newswire (Thu, 2-Apr 8:25 AM ET)
PRNewswire (Wed, 1-Apr 2:06 PM ET)
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 19-Mar 2:02 PM ET)
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 16-Mar 11:00 AM ET)
Globe Newswire (Fri, 27-Feb 3:02 PM ET)
Globe Newswire (Thu, 26-Feb 12:06 PM ET)
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
Masimo trades on the NASDAQ stock market under the symbol MASI.
As of April 27, 2026, MASI stock price climbed to $178.66 with 199,827 million shares trading.
MASI has a beta of 0.70, meaning it tends to be less sensitive to market movements. MASI has a correlation of 0.05 to the broad based SPY ETF.
MASI has a market cap of $9.36 billion. This is considered a Mid Cap stock.
Last quarter Masimo reported $413 million in Revenue and $1.16 earnings per share. This beat revenue expectation by $4 million and missed earnings estimates by -$.33.
In the last 3 years, MASI traded as high as $195.82 and as low as $75.22.
The top ETF exchange traded funds that MASI belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.
MASI has underperformed the market in the last year with a price return of +9.9% while the SPY ETF gained +31.9%. However, in the short term, MASI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +26.3% vs +3.8% return in SPY. But in the last 2 weeks, MASI shares have been beat by the market, returning +0.2% compared to an SPY return of +5.1%.
MASI support price is $178.29 and resistance is $178.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MASI shares will trade within this expected range on the day.